Carbidopa 25 MG / Levodopa 250 MG Oral Tablet [Sinemet]

Known as: Sinemet 25-250 (carbidopa / levodopa) Oral Tablet, Sinemet 25 MG / 250 MG Oral Tablet, Sinemet 25/250 Oral Tablet 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1988-2016
01219882016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Sinemet® is a combination of carbidopa and levodopa (L-dopa) that is used to treat Parkinson’s disease and syndrome. L-dopa is… (More)
Is this relevant?
1993
1993
The paper reports plasma levels of levodopa (LD), its main metabolites [dopamine, dihydroxyphenylacetic acid, homovanillic acid… (More)
Is this relevant?
1991
1991
Twenty patients with moderately severe Parkinson's disease entered an open study of the efficacy and safety of a slow release… (More)
Is this relevant?
1991
1991
Almost all patients with idiopathic Parkinson's disease respond to levodopa and progress steadily, requiring an increased overall… (More)
Is this relevant?
1988
1988
Patients with moderate to advanced Parkinson's disease may have prominent levodopa-related motor fluctuations. In a double-blind… (More)
Is this relevant?
1988
1988
Five patients with advanced Parkinson's disease and fluctuations in therapeutic response to levodopa participated in, and four… (More)
Is this relevant?